Similar Posts
Psychedelic Therapy As Employee Health Benefit Is Becoming Possible and the First Results Are In
No fewer than 50 companies have shown interest in offering psychedelic therapy to their employees through healthcare plan startup Enthea.
Spotlight in Focus: Opioid Crisis Demands Psychedelic Innovation, Yesterday
This month’s “Spotlight in Focus” features candid conversation with an opioid addict, and the director writes how psychedelic therapy can help.
Psychedelic Business Spotlight – June 10
This week in psychedelic business news: Cybin acquires a Phase 1 DMT trial from Entheon; Numinus completed the acquisition of Novamind, MindMed’s stock is removed from an index; and more!
Forgotten Psychedelics: LSA — Also Known as Ololiuqui
Meet LSA: LSD’s less intense but introspective cousin found in the seeds of morning glories and other plants. Here’s everything you need to know about the origins, effects, and uses of LSA.
Wake Receives First-Ever Approval for Psilocybin Microdose Study for Anxiety and Depression
In the first approval of its kind, Wake Network will study the effects of microdosing psilocybin on anxiety and depression.
Jon Stewart ‘Would Love’ to Try Microdosing Psychedelics
The comedian publicly expresses interest in the mental health treatment trend the same day as Paul Stamets’ massive microdosing study results were published.
